How Fast Is Zegalogue Compared to Traditional Glucagon Kits?
Zegalogue (dasiglucagon) reaches peak glucose levels in 30 minutes after subcutaneous injection, with glucose increasing above baseline within 10 minutes.[1] Traditional glucagon kits, like Glucagon Emergency Kit (glucagon HCl), take 8-12 minutes for initial glucose rise but peak at 50 minutes.[2][3]
Zegalogue acts faster overall, driven by its ready-to-use autoinjector design that skips reconstitution—traditional kits require mixing powder with diluent, adding 1-2 minutes.[1][4]
What Do Clinical Trials Show Head-to-Head?
In a Phase 3 trial of 99 patients with insulin-induced hypoglycemia, Zegalogue reversed hypoglycemia (glucose ≥70 mg/dL or ≥15 mg/dL rise) in 99% of cases at 30 minutes, versus 96% for standard glucagon at the same endpoint. Median time to reversal was similar (12 minutes for both), but Zegalogue's plasma levels peaked quicker.[5]
Another study confirmed Zegalogue's glucose response starts within 10 minutes and sustains longer than nasal Baqsimi (8-15 minutes onset).[1]
Why Does Speed Matter in Hypoglycemia Emergencies?
Faster peak action reduces seizure or coma risk during severe hypoglycemia, especially when caregivers (not trained medically) administer it. Zegalogue's prefilled syringe eliminates errors in mixing, a common delay with kits.[4][6]
When Does Zegalogue's Patent Expire?
Zegalogue's key composition-of-matter patent (US 9,770,412) expires in 2036, with pediatric exclusivity to 2037. No Paragraph IV challenges filed yet.[7]
How Do Costs and Availability Compare?
Zegalogue costs $3,000-$4,000 per two-dose carton, higher than Glucagon Emergency Kit ($200-$400), but easier for lay use.[8] Both covered by most insurance for type 1 diabetes patients.
[1] Zegalogue Prescribing Information
[2] Glucagon Emergency Kit Prescribing Information
[3] Lindner et al., Diabetes Care (2021); DOI:10.2337/dc20-2120
[4] American Diabetes Association Standards of Care (2023)
[5] Novo Nordisk Phase 3 Data (FDA Approval Summary, 2021)
[6] Seaquist et al., Diabetes Technol Ther (2018)
[7] DrugPatentWatch.com - Zegalogue Patents
[8] GoodRx Pricing (2024 averages)